RLMD
#2948
Relmada Therapeutics, Inc. - Common Stock
4.5 2 USD
-0.01%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-0.66%
Monthly Change
-13.58%
6 month change
-0.22%
Year Change
+444.58%
Previous Close
4.5 5
Open
4.5 2
Low
4.5 2
High
4.5 2
Volume
48
Financials
- Market Capitalization 482.15 M
- Employee 17
- Founded 2004
- CEO N/A
- Website www.relmada.com
- Headquarter Nevada, United States
- FIGI BBG003MKSL16
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-3.33
Price to sales ratio
-2 407.45
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2918 |  CCCC C4 Therapeutics, Inc. - Common Stock | 4.10 USD | -3.30% | 0.00% | +18.84% | +62.06% | 504.40 M USD | ||
| 2939 |  EVMN Evommune, Inc. Common Stock | 13.43 USD | -4.95% | -2.61% | +20.88% | -22.46% | 487.40 M USD | ||
| 2956 |  RZLT Rezolute, Inc. - Common Stock | 4.98 USD | -1.19% | +6.18% | +1.01% | -31.69% | 479.54 M USD | ||
| 2957 |  PBYI Puma Biotechnology Inc - Common Stock | 9.24 USD | +0.87% | -0.22% | +16.08% | +83.70% | 476.97 M USD |
Frequently asked questions about Relmada Therapeutics, Inc. Common Stock
What is the Relmada Therapeutics, Inc. Common Stock stock price today?
The current price of Relmada Therapeutics, Inc. Common Stock (RLMD) is 4.52. Over the past 24 hours, the stock has changed by -0.66%. Follow the RLMD chart for real-time price dynamics.
What is the stock ticker of Relmada Therapeutics, Inc. Common Stock?
Relmada Therapeutics, Inc. Common Stock trades under the ticker RLMD. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Relmada Therapeutics, Inc. Common Stock stock going up?
RLMD has changed by -3.42% over the last week, -13.58% over the last month, and +444.58% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Relmada Therapeutics, Inc. Common Stock?
Relmada Therapeutics, Inc. Common Stock currently has a market capitalization of 482.15 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Relmada Therapeutics, Inc. Common Stock earnings last quarter?
Last quarter, Relmada Therapeutics, Inc. Common Stock reported earnings of -0.11 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Relmada Therapeutics, Inc. Common Stock revenue for the last quarter?
Relmada Therapeutics, Inc. Common Stock reported quarterly revenue of -37.29 K. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Relmada Therapeutics, Inc. Common Stock net income for the last quarter?
Relmada Therapeutics, Inc. Common Stock reported net income of -12.91 M for the last quarter. The previous quarter showed -19.05 M, which means net income changed by +32.22%.
How many employees does Relmada Therapeutics, Inc. Common Stock have?
As of the latest available data, Relmada Therapeutics, Inc. Common Stock has 17 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Relmada Therapeutics, Inc. Common Stock stock?
You can buy Relmada Therapeutics, Inc. Common Stock (RLMD) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Relmada Therapeutics, Inc. Common Stock stock?
Investing in Relmada Therapeutics, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the RLMD chart and related analysis on metatrader.com as part of your research.